Endoscopic ultrasound-guided interstitial chemotherapy in the pancreas: results in a canine model

Endoscopy. 2007 Jun;39(6):530-4. doi: 10.1055/s-2007-966353.

Abstract

Background and study aim: Interstitial chemotherapy using surgically implanted, biodegradable polymers has been reported. Our aim in this study was to investigate the feasibility and safety of endoscopic ultrasound- (EUS-) guided interstitial chemotherapy of the pancreas in a canine model.

Materials and methods: A therapeutic 19-gauge needle with a large channel was inserted into the pancreas under EUS guidance. The polymers for sustained intratumoral release of 5-fluorouracil were implanted into the tissue by the needle. After 14 days of clinical observation, the animals were sacrificed and the tissue response to the local chemotherapy was examined.

Results: All the polymers were implanted successfully and no implant migration occurred. Localized tissue fibrous necrosis was achieved in the pancreas, without significant complications. The apoptotic index of the tissue within 1 cm of the focus increased. Biochemical parameters were normal in all the dogs.

Conclusions: EUS-guided implantation of polymers is a safe, simple, and minimally invasive technique for interstitial chemotherapy in the pancreas.

MeSH terms

  • Animals
  • Antimetabolites, Antineoplastic / administration & dosage*
  • Dogs
  • Endosonography*
  • Feasibility Studies
  • Fluorouracil / administration & dosage*
  • Injections, Intralesional
  • Models, Animal
  • Pancreas / diagnostic imaging*
  • Pancreas / pathology
  • Polymers / administration & dosage

Substances

  • Antimetabolites, Antineoplastic
  • Polymers
  • Fluorouracil